ImageneBio (IMA) Non-Current Deffered Revenue (2020 - 2024)

ImageneBio has disclosed Non-Current Deffered Revenue across 4 years of filings, most recently posting $1.9 million for Q4 2024.

• Non-Current Deffered Revenue for Q4 2024 came in at $1.9 million, changed N/A year-over-year; the trailing twelve-month figure through Dec 2024 was $1.9 million (changed N/A YoY), and the FY2024 annual result was $1.9 million, changed N/A from the prior year.
• Non-Current Deffered Revenue came in at $1.9 million for Q4 2024 at ImageneBio, down from $2.5 million in the prior quarter.
• In the past five years, Non-Current Deffered Revenue ranged from a high of $35.1 million in Q4 2020 to a low of $1.9 million in Q4 2024.
• The 4-year median for Non-Current Deffered Revenue is $7.7 million (2021), against an average of $14.9 million.
• Across the five-year window, Non-Current Deffered Revenue slumped 78.15% in 2021 and sank 88.84% in 2022, its largest moves.
• ImageneBio's Non-Current Deffered Revenue stood at $35.1 million in 2020, then plunged by 78.15% to $7.7 million in 2021, then tumbled by 67.41% to $2.5 million in 2022, then retreated by 24.54% to $1.9 million in 2024.
• The last three Non-Current Deffered Revenue figures came in at $1.9 million (Q4 2024), $2.5 million (Q3 2022), and $3.8 million (Q2 2022), per Business Quant data.